Cargando…
RUNX1 loss renders hematopoietic and leukemic cells dependent on IL-3 and sensitive to JAK inhibition
Disease-initiating mutations in the transcription factor RUNX1 occur as germline and somatic events that cause leukemias with particularly poor prognosis. However, the role of RUNX1 in leukemogenesis is not fully understood, and effective therapies for RUNX1-mutant leukemias remain elusive. Here, we...
Autores principales: | Fan, Amy C., Nakauchi, Yusuke, Bai, Lawrence, Azizi, Armon, Nuno, Kevin A., Zhao, Feifei, Köhnke, Thomas, Karigane, Daiki, Cruz-Hernandez, David, Reinisch, Andreas, Khatri, Purvesh, Majeti, Ravindra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541186/ https://www.ncbi.nlm.nih.gov/pubmed/37581927 http://dx.doi.org/10.1172/JCI167053 |
Ejemplares similares
-
The TRACE-Seq method tracks recombination alleles and identifies clonal reconstitution dynamics of gene targeted human hematopoietic stem cells
por: Sharma, Rajiv, et al.
Publicado: (2021) -
Convergent Epigenetic Evolution Drives Relapse in Acute Myeloid Leukemia
por: Nuno, Kevin A., et al.
Publicado: (2023) -
A Humanized Ossicle-niche Xenotransplantation Model Enables Improved Human Leukemic Engraftment
por: Reinisch, Andreas, et al.
Publicado: (2016) -
Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6
por: Bak, Rasmus O, et al.
Publicado: (2017) -
Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability
por: Thomas, Daniel, et al.
Publicado: (2023)